Croton membranaceus is used by herbalists and traditional healers in Ghana for the management of various cancers, especially prostate cancers. A methanolic extract of the roots showed cytotoxic activities against two cancer cell lines, and bioassayguided fractionation of this extract revealed that the cytotoxic activity resided mostly in the ethyl acetate fraction. Six compounds were isolated from this fraction, including a new furano-clerodane diterpenoid (1), for which the trivial name crotomembranafuran is suggested. This compound exhibited an IC 50 value of 4.1 µg/mL (10.6 µM) against human prostate (PC-3) cells, providing some support for the traditional use of C. membranaceus in the treatment of cancers.
In an earlier study [1] , we evaluated the cytotoxic activities of the methanolic extracts of ten plant species against three human cancer cell lines, DLD-1 (colon carcinoma), MCF-7 (breast carcinoma) and M14 (melanoma), using the MTT assay. The results showed that C. membranaceus root extract exhibited cytotoxic activities against the DLD-1 and MCF-7 cells (IC 50 = 16.0 and 17.4 µg/mL, respectively). These results lend some support for the use of this species in traditional medicine for the treatment of cancer, and compound isolation was deemed worthwhile. In the current study, bioassay-guided fractionation of the methanolic extract of C. membranaceus root revealed that the cytotoxic activity resided mostly in the ethyl acetate fraction. Separation of this fraction using column chromatography resulted in the isolation of six compounds, including a new furano-clerodane diterpenoid [12- Compound 1 was isolated as a colorless semi-solid, readily soluble in chloroform. The mass spectrum (EI) gave a molecular ion peak at m/z 388 and the molecular formula was determined as C 22 H 28 O 6 from accurate mass measurements. The presence of a β-substituted furan ring attached to a carbonyl group was suggested by the peak at m/z 95 (C 5 H 3 O 2 ) in the mass spectrum [2] . The 1 H NMR spectrum of 1 (Table 1) , showed signals at δ 6.73 (1H, dd, J = 0.9, 1.9 Hz, H-14), 7.40 (1H, dd, J = 1.5, 1.9 Hz, H-15) and 8.04 (1H, dd, J = 0.9, 1.5 Hz, H-16), indicating the presence of a furan ring, similar to that reported for crotocorylifuran isolated from Croton zambesicus [3] . Singlets at δ 0.98 (Me-20), 1.28 (Me-19), 3.60 (OMe-17) and 3.65 (OMe-18) demonstrated the presence of four methyl groups, representing two quaternary bound methyl groups and two methyl esters. The 1 H NMR spectrum also indicated an olefinic proton signal at δ 6.58 (H-3).
The 13 C NMR spectral data were consistent with the 1 H NMR results above. The signals at δ 147. corresponded to the carbons of the two methyl and two methoxyl groups, respectively. Also, quaternary carbon signals at δ 167.5 and 175.1 (C-17 and C-18) indicated the presence of two ester carbonyl groups. The chemical shift of the latter suggested conjugation with a double bond (C-3, 4), as in crotocorylifuran [3] . In addition, a quaternary carbon peak at δ 194.3 (C-12) suggested that the molecule contained a keto group. The 1 H-1 H COSY spectrum revealed the presence of two spin systems, H-3, 2, 1, 10 and H-6, 7, 8, in addition to the protons of the furan ring. The CH 3 -20 signal at δ 0.98 showed a 2 J H-C correlation with C-9 and 3 J correlations with C-8, C-10 and C-11, thus establishing a link between the two 1 H-1 H spin systems, as well as with H-11, which showed a 2 J correlation with C-12. The CH 3 -19 signal at δ 1.28 showed a 2 J H-C correlation with C-5 and 3 J correlations with C-6 and C-10 confirming the position of the C-19 methyl group at the ring junction. The remaining methylester group was assigned to C-8 on account of the 1 H resonance of H-8 at δ 3.17; the β-substituted furan ring was placed on C-11, confirmed by the observation of a NOE connection between H-11 and H-16 ( Figure 1B) . NOE connections were detected between CH 3 -20, H-7α and CH 3 -19 ( Figure 1A) , indicating that the two methyl groups have the same relative configuration, while connections between H-10 and H-8 are consistent with a trans ring junction and, therefore, this places the C-8 methylester in the same relative configuration as the 19-and 20-methyl groups ( Figure 1B) .
Compound 1 was identified as the novel furanoclerodane diterpenoid [12-oxo-15,16-epoxy-3,13(16), 14-clerodatrien-17,18-dioic acid dimethyl ester], for which we propose the trivial name crotomembranafuran. Although this is the first report of 1, other furano-clerodane diterpenoids have been obtained from species of Croton [2, [4] [5] [6] [7] . In particular, 1 closely resembles 12-hydroxyhardwickic acid, a constituent of C. sonderianus [4] and, by analogy, the stereochemistry of 1 has been assigned as published for 12-hydroxyhardwickic acid. The identities of the five other compounds isolated were established by comparing their spectral data with those in the literature [8] [9] [10] [11] . Julocrotine has previously been obtained from C. membranaceus [8] , but this is the first report of β-sitosterol, β-sitosterol-3-D-glucoside, gomojoside H and DL-threitol in this species.
In cytotoxicity tests, 1 exhibited modest activity against human prostate cancer (PC-3) cells, (IC 50 = 4.1 ± 0.6 µg/mL; 10.6 µM), while the IC 50 values of the other compounds isolated were > 5 µg/mL. In contrast to the crude extracts of C. membranaceus, 1 was found to be inactive against both DLD-1 and MCF-7 cells (IC 50 > 5 µg/mL) indicating that there are likely to be other cytotoxic compounds present in this species.
Experimental
General experimental procedures: 1 H (600.17 MHz) and 13 C NMR (150.91 MHz) spectra were recorded on a JEOL (ECA-600 NMR) spectrometer. Electrospray mass spectrometry (ESIMS) was conducted in methanol and DMSO on a Micromass QUATTRO Ultima (with the sample infused through a syringe pump). Electron-impact mass spectra (EIMS) and accurate mass determinations were conducted on a Micromass Autospec M Spectrometer at the Advanced Chemical and Materials Analysis Unit, University of Newcastle, Newcastle-upon-Tyne, U.K. UV spectra were recorded on a Cary 400 B10 spectrophotometer and optical rotation was measured on a Perkin Elmer 341 polarimeter.
Plant material: Croton membranaceus root was collected in Mampong -Akwapem, Ghana (2004) and authenticated at the Centre for Scientific Research into Plant Medicine (CSRPM), Mampong-Akwapem, Ghana, where a voucher specimen (CSRPM/011/03) has been deposited. The material was dried in the shade and comminuted into suitable particle-sized powder for extraction.
Extraction and isolation:
Powdered C. membranaceus root (500 g) was extracted with methanol (2.5 L) using a Soxhlet extractor and the extract obtained was concentrated to a syrupy mass under reduced pressure before drying completely over silica gel in a vacuum chamber at room temperature, thus producing a dark brown organic extract (15 g). The above was repeated and the combined dried extracts (30 g) were stored in a refrigerator until used further. The methanolic extract (25 g) was fractionated by column chromatography over silica gel 60 G (50 g, average particle size 5-40 µm) (Merck) and sequentially eluted with n-hexane, ethyl acetate, and methanol, which were then concentrated under reduced pressure at 45 o C to obtain n-hexane (2.6 g), ethyl acetate (14.4 g), and methanol (7.8 g) fractions. Cytotoxicity tests showed that the activity resided mostly in the ethyl acetate fraction and column chromatography of this fraction eluting with n-hexane containing increasing amounts of ethyl acetate yielded eight fractions (F A -F H ). Fraction F A (1.50 g) was re-chromatographed over silica gel eluted with n-hexane-ethyl acetate (4:1) and a sub-fraction F A2 further purified by repetitive chromatography on silica gel with n-hexane-ethyl acetate (4:2) to afford compound 1 (51 mg, 0.01% with respect to the dried plant material). Further column chromatography of the other fractions over silica gel led to the isolation of additional compounds, thus: F B (2.02 g) -julocrotine, (20 mg, 0.004%), F C (2.07 g) -(β-sitosterol), (20.3 mg, 0.0046%) and β-sitosterol-3-D-glucoside, (40 mg, 0.008%), F D (1.56 g) -gomojoside H, (9 mg, 0.0018%), F G (1.951 g) and F H (2.07 g) -DL-threitol, (132 mg, 0.026%). Cytotoxicity assay: Human breast (MCF-7), colon adenocarcinoma (DLD-1) and prostate cancer (PC-3) cells were available at the Institute for Cancer Therapeutics, University of Bradford. Cytotoxic activities were assessed using the MTT method with a drug-cell exposure time of 96 h [12] . Doxorubicin was used as positive control against MCF-7 and DLD-1 cells with IC 50 values of 73 and 80 nM, respectively. Doxorubicin and 5-fluorouracil were used as standard anticancer agents against PC-3 cells and exhibited IC 50 values of 10.7 µM and 1.17 µM respectively.
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